| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.027 | 0.6 |